Tomohiro Araki Selected Research

Tomohiro Araki Research Topics

Disease

8	Seizures (Absence Seizure) 04/2004 - 07/2002
3	Parkinson Disease (Parkinson's Disease) 11/2022 - 01/2019
3	Aneurysm (Aneurysms) 04/2018 - 12/2002
3	Fatty Liver 09/2016 - 12/2012
3	Diabetes Complications 04/2011 - 06/2002
2	Rupture 04/2018 - 01/2011
2	Atherosclerosis 12/2004 - 06/2002
2	Brain Injuries (Brain Injury) 01/2004 - 09/2002
1	Siderosis 11/2022
1	Brain Edema (Cerebral Edema) 02/2022
1	Aortic Dissection 04/2018
1	Thrombosis (Thrombus) 04/2018
1	Embolism (Embolus) 02/2017
1	Chronic Subdural Hematoma 01/2016
1	Ischemic Stroke 01/2011
1	Transient Ischemic Attack 01/2011
1	Brain Ischemia (Cerebral Ischemia) 01/2011
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2010
1	Intracranial Vasospasm 03/2010
1	Hyperglycemia 06/2007
1	Inflammation (Inflammations) 06/2007
1	Rhabdomyosarcoma 04/2004
1	Parasitemia 12/2003
1	Necrosis 05/2003
1	Nervous System Diseases (Neurological Disorders) 09/2002
1	Central Nervous System Diseases (CNS Diseases) 09/2002
1	Hashimoto's encephalitis 09/2002
1	Ischemia 09/2002
1	Epilepsy (Aura) 07/2002

Drug/Important Bio-Agent (IBA)

6	Kainic Acid (Kainate)IBA 04/2004 - 07/2002
4	Advanced Glycation End ProductsIBA 04/2011 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 05/2003
2	Alcohol OxidoreductasesIBA 10/2015 - 12/2012
2	NAD (NADH)IBA 10/2015 - 12/2012
2	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 06/2007 - 12/2004
2	Diazepam (Valium)FDA LinkGeneric 04/2004 - 09/2002
2	Caspase 8 (Caspase-8)IBA 04/2004 - 09/2003
2	Death-Associated Protein KinasesIBA 01/2004 - 09/2003
1	Indicators and Reagents (Reagents)IBA 04/2018
1	9,10-phenanthrenequinoneIBA 09/2016
1	ethyl 4-chloro-3-oxobutanoateIBA 09/2016
1	SolventsIBA 09/2016
1	EnzymesIBA 10/2015
1	polyethylene glycol 300IBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 03/2010
1	TenascinIBA 03/2010
1	Transcription Factors (Transcription Factor)IBA 04/2004
1	Antisense OligonucleotidesIBA 04/2004
1	Bcl-2-Like Protein 11IBA 04/2004
1	Lorazepam (Ativan)FDA LinkGeneric 04/2004
1	Biotin (Vitamin H)FDA Link 12/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2003
1	Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA 09/2003
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 09/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2003
1	MAP Kinase Kinase Kinase 5IBA 05/2003
1	MAP Kinase Kinase 3IBA 05/2003
1	protein phosphatase 5IBA 05/2003
1	Molecular Chaperones (Chaperone, Molecular)IBA 05/2003
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2003
1	Inhibitor of Apoptosis ProteinsIBA 05/2003
1	Phenobarbital (Luminal)FDA Link 12/2002
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2002
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2002
1	AutoantigensIBA 09/2002
1	Phosphopyruvate Hydratase (Enolase)IBA 09/2002
1	NeurotoxinsIBA 09/2002
1	CaspasesIBA 07/2002
1	Peptide Hydrolases (Proteases)FDA Link 07/2002
1	Lamin Type A (Lamin A)IBA 07/2002
1	Caspase 6IBA 07/2002

Therapy/Procedure

3	Deep Brain Stimulation 11/2022 - 01/2019
2	Therapeutics 01/2019 - 02/2017
2	Endovascular Procedures 02/2017 - 01/2011
2	Craniotomy 01/2016 - 01/2011
1	Stents 04/2018
1	Thrombectomy 02/2017
1	Laminectomy 01/2016
1	Surgical Instruments (Clip) 01/2011
1	Cerebral Revascularization 01/2011
1	Lasers (Laser) 09/2002